Toxicological Risk Assessment for Fragrances

1. Why Toxicological Evaluation is Essential

Before any cosmetic product can be sold, including perfumes, essential oils, or any natural aromatic compounds, it needs a Toxicological Risk Assessment (TRA). It also needs to be included in a Cosmetic Product Safety Report (CPSR). Under the EU Regulation (EC) No 1223/2009, and the UK Cosmetic Regulation 2020 (SI 2020/1466), a scientific investigation must be done to assess the toxicological profile of a cosmetic product’s fragrance components, including concentration limits and possible adverse health effects. Phoenix Safety Consultants conducts expert-level toxicological risk assessments for fragrances, ensuring compliance with the standards set by the IFRA 51st Amendment, SCCS Notes of Guidance, and all EU/UK cosmetic safety principles.

2. Regulatory Framework for Fragrance Safety

Toxicological evaluation of cosmetic fragrances is legally based on the following:

• Based on Regulation (EC) No 1223/2009 and the UK Cosmetic Regulation 2020, all cosmetic products undergo safety assessment based on their composition, exposure routes, and toxicity (Annex I, Part A & B).
• A qualified safety assessor, as per Article 10 of the Regulation, evaluates safety using each ingredient's toxicological profile.
• The International Fragrance Association (IFRA) 51st Amendment sets global safety standards for fragrance ingredients, along with concentration limits and prohibitions or restrictions for different categories (leave-on, rinse-off, fine fragrance, etc.).
• The Scientific Committee on Consumer Safety (SCCS) also sets toxicological reference values and guidelines, such as NOAEL (No Observed Adverse Effect Level) and the Margin of Safety (MoS) criteria.

All these frameworks ensure that all fragrances undergo human health risk assessment for dermal, inhalation, and systemic exposure prior to CPSR approval or market release.

3. Step-by-Step Risk Analysis

At Phoenix Safety Consultants, all fragrance formulations undergo toxicology assessments following IFRA and SCCS guidelines. This includes a multi-tiered evaluation of the formulation’s constituent parts and a full quantitative exposure analysis to confirm safety for the intended cosmetic category.

Ingredient-Level Toxicological Profiling

For all formulation constituents—essences and fragrance chemicals—the toxicological profiling covers INCI name, CAS, EC number, purity, and concentration. Data are sourced from SCCS opinions, ECHA databases, IFRA guidelines, and peer-reviewed journals. Each component is assessed for acute toxicity, skin/eye irritation, sensitisation, and systemic toxicological endpoints.

Allergen Content Verification

For allergens listed in Annex III of Regulation (EC) No 1223/2009 such as Limonene, Linalool, Citronellol, Coumarin, and Geraniol, Phoenix verifies quantification and compliance with threshold limits—≥0.001% for leave-on and ≥0.01% for rinse-off products—to ensure correct labelling and consumer protection.

Toxicological Benchmarks: NOAEL and Margin of Safety (MoS)

The NOAEL value for each toxicological constituent is calculated, followed by the Margin of Safety (MoS) in accordance with SCCS methodology:

MoS = NOAEL / SED

where SED is the Systemic Exposure Dose based on product type, concentration, area of application, and frequency. An MoS ≥100 confirms adequate systemic safety for typical exposure.

Endpoint Evaluation

Every perfume is evaluated for potential dermal sensitisation, phototoxicity, reproductive toxicity, and inhalation safety. Category-specific exposure factors (leave-on, rinse-off, fine fragrance) are applied according to IFRA methodology to ensure full regulatory compliance.

This ensures every perfume meets the quantitative and qualitative risk assessment criteria required by IFRA, the EU, and the UK before inclusion in the CPSR, guaranteeing product safety within approved limits.

4. Phoenix Safety Consultants’ Methodology: Dual Regulatory and Scientific Approach

Phoenix Safety Consultants applies a dual-framework assessment that merges IFRA category validation with EU toxicological risk modelling. This ensures that every fragrance is evaluated for both scientific validity and legal compliance.

IFRA 51st Amendment Evaluation: Safety Standards Assessment

Every fragrance undergoes evaluation against IFRA global safety standards. Ingredient compliance is verified across all IFRA product categories (Category 1–12) through dermal and inhalation exposure calculations. Phoenix checks each restricted or prohibited substance (e.g., hydroxycitronellal, isoeugenol, methyl 2-octynoate) to ensure concentration limits align with intended cosmetic use.

EU Toxicological Risk Calculation

In parallel with IFRA compliance, Phoenix performs quantitative toxicological risk assessments in line with SCCS Notes of Guidance (12th Edition). This includes derivation of Systemic Exposure Doses (SEDs), estimation of aggregate MoS values, and qualitative analysis of sensitisation, genotoxicity, and reproductive hazard endpoints.

This combined methodology integrates empirical IFRA industry standards with EU scientific risk models to deliver a defensible, audit-ready report for inclusion in CPSR, PIF documentation, and regulatory audits.

5. What Clients Need to Provide

To complete a scientifically robust toxicological risk assessment, Phoenix Safety Consultants requires the following:

• Full fragrance composition with INCI name, CAS, EC number, and % concentration (w/w) for each ingredient.
• IFRA Certificate of Conformity from the fragrance supplier, indicating product category and usage level.
• Safety Data Sheets (SDS) compliant with REACH Annex II and CLP Regulation for each fragrance or essential oil component.
• Intended cosmetic category (e.g., body lotion, perfume, shampoo, deodorant) to determine exposure route and dosage.
• Usage concentration of the fragrance in the finished cosmetic product (%).
• Available toxicological or analytical data such as GC-MS profiles or impurity analyses, if applicable.

This documentation allows Phoenix to build the complete hazard profile, perform exposure modelling, and demonstrate compliance with IFRA and SCCS safety standards.

6. What You Receive

After completion, clients receive a professional Toxicological Risk Assessment Report suitable for regulatory submission. Deliverables include:

• A toxicological summary for each ingredient detailing the NOAEL and MoS.
• A Margin of Safety (MoS) table showing systemic and dermal exposure calculations.
• An IFRA compliance verification for the declared cosmetic category.
• A CPSR-ready toxicological conclusion for inclusion in Part B of the Cosmetic Product Safety Report.

Pricing ranges from £75 – £110, depending on formulation complexity, ingredient count, and data availability. Reports are typically completed within 3–5 business days after receiving the required documentation.

7. Ensure Your Fragrance Is Scientifically and Legally Safe

Make sure your fragrance formulation adheres to the highest safety and compliance standards. Get your Toxicological Risk Assessment conducted by Phoenix Safety Consultants to confirm compliance with EU Regulation (EC) No 1223/2009, UK Cosmetic Regulation 2020, and IFRA 51st Amendment.

We guarantee scientific integrity, regulatory precision, and complete CPSR readiness.

→ Request Toxicological Risk Assessment for Fragrances
→ Learn About Cosmetic Product Safety Reports (CPSR)
→ Explore Product Information File (PIF) Services